BriaCell Therapeutics (BCT) Competitors C$1.03 +0.02 (+1.98%) As of 08/1/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsBuy This Stock BCT vs. QPT, KNE, RVV, PBS, MFS, SVS, PAS, ICO, COT, and CZOShould you be buying BriaCell Therapeutics stock or one of its competitors? The main competitors of BriaCell Therapeutics include Quest PharmaTech (QPT), Kane Biotech (KNE), Revive Therapeutics (RVV), Pacgen Life Science Co. (PBS.V) (PBS), Medifocus Inc. (MFS.V) (MFS), Solarvest BioEnergy (SVS), Pascal Biosciences (PAS), iCo Therapeutics (ICO), Cotinga Pharmaceuticals Inc. (COT.V) (COT), and Ceapro (CZO). These companies are all part of the "biotechnology" industry. BriaCell Therapeutics vs. Its Competitors Quest PharmaTech Kane Biotech Revive Therapeutics Pacgen Life Science Co. (PBS.V) Medifocus Inc. (MFS.V) Solarvest BioEnergy Pascal Biosciences iCo Therapeutics Cotinga Pharmaceuticals Inc. (COT.V) Ceapro Quest PharmaTech (CVE:QPT) and BriaCell Therapeutics (TSE:BCT) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends. Does the media prefer QPT or BCT? In the previous week, BriaCell Therapeutics had 1 more articles in the media than Quest PharmaTech. MarketBeat recorded 1 mentions for BriaCell Therapeutics and 0 mentions for Quest PharmaTech. Quest PharmaTech's average media sentiment score of 0.00 beat BriaCell Therapeutics' score of -1.32 indicating that Quest PharmaTech is being referred to more favorably in the media. Company Overall Sentiment Quest PharmaTech Neutral BriaCell Therapeutics Negative Which has stronger earnings and valuation, QPT or BCT? BriaCell Therapeutics has lower revenue, but higher earnings than Quest PharmaTech. Quest PharmaTech is trading at a lower price-to-earnings ratio than BriaCell Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuest PharmaTechC$38.87K195.80-C$2.88M-C$0.02-2.25BriaCell TherapeuticsN/AN/A-C$2.37M-C$1.32-0.78 Which has more risk and volatility, QPT or BCT? Quest PharmaTech has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500. Comparatively, BriaCell Therapeutics has a beta of 1.83, suggesting that its share price is 83% more volatile than the S&P 500. Do insiders and institutionals believe in QPT or BCT? 15.0% of BriaCell Therapeutics shares are held by institutional investors. 17.1% of Quest PharmaTech shares are held by company insiders. Comparatively, 9.3% of BriaCell Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is QPT or BCT more profitable? BriaCell Therapeutics' return on equity of 536.29% beat Quest PharmaTech's return on equity.Company Net Margins Return on Equity Return on Assets Quest PharmaTechN/A -6.28% -1.07% BriaCell Therapeutics N/A 536.29%-122.71% SummaryBriaCell Therapeutics beats Quest PharmaTech on 6 of the 11 factors compared between the two stocks. Get BriaCell Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BCT and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BCT vs. The Competition Export to ExcelMetricBriaCell TherapeuticsBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$2.66MC$134.48MC$5.49BC$6.20BDividend Yield13.70%3.74%4.73%6.72%P/E Ratio-0.783.8128.7563.43Price / SalesN/A4,246.60372.201,250.99Price / CashN/A13.1935.4583.29Price / Book5.0039.388.274.87Net Income-C$2.37M-C$90.99MC$3.25BC$301.20M7 Day Performance-4.63%-1.82%-3.72%-2.26%1 Month Performance-74.19%11.23%4.30%0.80%1 Year Performance9.57%189.82%25.87%26.63% BriaCell Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BCTBriaCell TherapeuticsN/AC$1.03+2.0%N/A+5.1%C$2.66MN/A-0.7816News CoverageNegative NewsQPTQuest PharmaTechN/AC$0.05+12.5%N/A+80.0%C$7.61MC$38.87K-2.25147,000Gap UpKNEKane BiotechN/AC$0.05+12.5%N/A-72.4%C$6.48MC$1.42M1.13N/ANews CoverageGap UpRVVRevive TherapeuticsN/AC$0.08+14.3%N/A+0.0%C$5.79MN/A-3.64N/AGap UpHigh Trading VolumePBSPacgen Life Science Co. (PBS.V)N/AC$0.03+20.0%N/A+0.0%C$1.94MC$302.08K-5.00N/AGap UpMFSMedifocus Inc. (MFS.V)N/AC$0.01flatN/A+0.0%C$1.85MC$2.23M-1.004,800SVSSolarvest BioEnergyN/AC$0.03flatN/A+0.0%C$1.52MC$740.00-0.63N/AGap DownPASPascal BiosciencesN/AC$0.02-25.0%N/A+0.0%C$984KN/A-1.506Gap DownICOiCo TherapeuticsN/AC$0.11flatN/A+0.0%C$952KN/A-10.50N/ACOTCotinga Pharmaceuticals Inc. (COT.V)N/AC$0.04-41.7%N/A+0.0%C$770KN/A-0.30N/AGap DownCZOCeaproN/AC$0.23-11.8%N/A+0.0%C$689KC$348.52K-2.83N/AGap Down Related Companies and Tools Related Companies QPT Alternatives KNE Alternatives RVV Alternatives PBS Alternatives MFS Alternatives SVS Alternatives PAS Alternatives ICO Alternatives COT Alternatives CZO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:BCT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCT Stock Alerts